fbpx

Dot Colagiovanni joins us and shares that she’s got a PhD in toxicology which she put to use in the biotech industry for 20 years until she became disillusioned with the FDA working slowly but also hedge funds coming in to biotech and driving decision making as opposed to the science. She wanted to bring medicine to market sooner at the same time as her son had to have a liver transplant. During the wait to find a liver, Dot wanted to be present and so she and she alone self medicated with cannabis after her son went to bed. She had never utilized cannabis medically and she says, cannabis helped her cope. She put two and two together and realized the cannabis industry was where she needed to be.

Transcript:

Speaker 2: Dot Giovanni joins us and shares that she's got a phd in toxicology, which you put to use in the biotech industry for 20 years until she became disillusioned with the FDA working slowly but also hedge funds coming into biotech and driving decision making as opposed to the science. She wanted to bring medicine to market sooner at the same time as their son had to have a liver transplant during the wait to find, deliver dot, want it to be present, and so she and she alone self medicated with cannabis after her son went to bed, she had never utilized cannabis medically and she says cannabis helped her cope. She put two and two together and realize that the cannabis industry was where she needed to be welcomed to cannabis economy. I'm your host, Seth Adler. Check us out on social with the handle can economy. That's two ends of the word Economy Dot Giovanni

Speaker 1: collage. Giovanni, that's not true. Do it phonetically for you. Do that. Oh No, no, no, no. I thought you were going to verbally do it phonetically. Do it that way. Collagey Avanti. That's it and that's why I think we went short on the situation, right, because my real name's Dorothy, so why add to the whole thing? We don't need that. It's just too long. Exactly. Alright, so dot Khaled. Giovanni, Giovanni. Yes. I just love it. Nice Jewish girl is what you are, right? Exactly. Not so much. All right, so we've got next frontier, bio sciences. We've got vera. Yeah, yeah, yeah, yeah. We've got next frontier. Bio Sciences. We've got. Vera, let's just make sure we understand what both of those things are. Okay. So next frontier. Bio Sciences is an IP company and brand management company based in Colorado. Vera wellness is our brand that we're launching this week.

Speaker 1: Oh, congratulation Colorado. Thank you. All right. You know you're in Vegas, right? Right now I'm in Vegas. Mj Biz con. That's how they say it was here in 2014 and it has grown so much. Substantial. Can't believe it was that. That was the first year in Vegas. Vegas at the Rio. The Rio. My goodness. What a, what? A, what? A place. What a place and tell her. You can see there I, yeah, there's no tales to be told. Oh No. Penn and teller, the magician that, yes, but the magic. But we have to, we have to find out what tells. You do have to tell. Right. So what are you doing in the cannabis industry? Is My first question to anybody that I haven't met before. Like why are you here? Why am I here? Well, good question. Um, I have a phd in toxicology that'll help.

Speaker 1: I worked in the biotech industry for 20 years and got a little disillusioned with what was happening as far as lack of FDA approval of drugs as well as uh, the hedge funds that were coming in and kind of driving the decision making rather than the science. Huh? Both ends kind of thing. Here's FDA kind of not doing it so great. And then from the top hedge funds being like, we want it done this way. And I decided I wanted to work on bringing medicines to market sooner and I had a personal, uh, I would say come to Jesus moment. Uh, in 2010 when my son had a liver transplant. How old was he at the time? He at the time was 10. Oh my goodness. And so little boy. There's something called the waiting period when you're waiting to get an organ and I can tell you as a mom, it was the most horrible three months of my life.

Read the full transcript:

Become a member to access to webinars, quarterly reports, contributor columns, shows, excerpts, and complete podcast transcripts

Become a Member

Already a member? Login here.